Information Library

Results for: Consulting - Phase I/IIa

In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions.  Search our library today.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Cancer Treatments and the Search for Value

    White Paper — April 2, 2012
    Cancer Treatment and the Search for Value In September 2011, The Economist Intelligence Unit surveyed 399 senior executives from the life sciences industry and payer

  • Accelerating Success in Oncology

    Brochure — March 9, 2012
    New Demands to Demonstrate Value Require New Strategy Proof of efficacy is no longer enough to ensure success in oncology. As the cost and complexity

  • DIA US 2012

    Event — Conference Date(s): June 24 - June 28, 2012
    Location: Philadelphia, PA Pennsylvania Convention Center
    Booth Number: 1401

  • ASCO 2012 – Accelerating Investigator Success in Oncology Trials

    Event — Conference Date(s): June 1 - June 4, 2012
    Location: Chicago, IL | McCormick Place
    Booth Number: 2062

  • Harish Dave Discusses ASH 2011

    Hear from the Experts — December 8, 2011
    Harish Dave discusses the American Society of Hematology annual meeting.

  • Quintiles Names New Global Head of Clinical & Data Operations

    Press Release — October 6, 2011 – Quintiles announced that Steven Skolsky has been appointed Global Head of its Clinical & Data Operations (CDO) unit.

  • Shifting Sands

    Media Coverage — September 2, 2011
    As the pressure to improve the productivity of clinical development programmes mounts on pharmaceutical companies, the current landscape for locating cost-effective clinical trials continues to evolve. One region attracting attention is the Middle East and North Africa.

  • A Focus on CNS

    Brochure — July 1, 2011
    Quintiles is your ally for broad and deep CNS expertise in every aspect of the drug development process.

  • The Molecular Biomarker Revolution in Non-Small Cell Lung Cancer

    White Paper — June 23, 2011
    In this new white paper Quintiles’ experts Christopher Ung, Jason Hill, Carrie Lee and Harish Dave review some of the most promising molecular pathways and targeted approaches for NSCLC, the critical role of diagnostics, and strategies to detect and address the emergence of resistance.

  • Biomarkers in Alzheimers Disease

    Presentation — March 17, 2011
    The Quintiles Innovation Unit shares their knowledge on the use of biomarkers in compound development in clinical trials.

Page 1 of 3 (27 results)

Subscribe to Email Based on Your Interests

Set preferences